Systematic review of 54 RCTs (2477 participants): cannabinoids eased cannabis use disorder, tics, insomnia and autistic traits vs placebo (mostly low certainty), not anxiety, psychosis or PTSD, and raised cocaine craving and all-cause adverse events (OR 1.75).
Meta-analysisn = 2,477
Wilson et al. The efficacy and safety of cannabinoids for the treatment of mental disorders and substance use disorders: a systematic review and meta-analysis